A study in The Journal of Clinical Endocrinology & Metabolism showed that adults with type 1 diabetes patients and an A1C of at least 8% had an increased risk for low-trauma fracture over four years after diabetes diagnosis than those with A1C levels below 7%, but the association between A1C and fracture risk was not evident among those with type 2 diabetes. The study of 47,604 patients with diabetes found that regardless of glycemic control, those with type 2 diabetes who received pioglitazone or rosiglitazone were more likely to experience a low-trauma fracture than nonusers.
Research compares A1C-fracture risk link in type 1, type 2 diabetes
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.